Convenient synthesis of pyrimidine 2'-deoxyribonucleoside monophosphates with important epigenetic marks at the 5-position.


Journal

Organic & biomolecular chemistry
ISSN: 1477-0539
Titre abrégé: Org Biomol Chem
Pays: England
ID NLM: 101154995

Informations de publication

Date de publication:
15 07 2020
Historique:
pubmed: 26 6 2020
medline: 26 6 2020
entrez: 26 6 2020
Statut: ppublish

Résumé

Methyl groups of thymine and 5-methylcytosine (5mC) bases in DNA undergo endogenous oxidation damage. Additionally, 5mC residues can be enzymatically deaminated or oxidized through either genetic alterations or the newly identified epigenetic reprogramming pathway. Several methods have been developed to measure the formation of modified DNA nucleobases including 32P-postlabeling. However, the postlabeling method is often limited by the absence of authentic chemical standards. The synthesis of monophosphate standards of nucleotide oxidation products is complicated by the presence of additional functional groups on the modified bases that require complex protection and deprotection strategies. Due to the emerging interest in the pyrimidine oxidation products, the corresponding protected 3'-phosphoramidites needed for solid-phase oligonucleotide synthesis have been reported, and several are commercially available. We report here an efficient synthesis of 3'-monophosphates from 3'-phosphoramidites and the subsequent enzymatic conversion of 3'-monophosphates to the corresponding 5'-monophosphates using commercially available enzymes.

Identifiants

pubmed: 32584362
doi: 10.1039/d0ob00884b
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Retracted Publication

Langues

eng

Sous-ensembles de citation

IM

Pagination

5164-5173

Commentaires et corrections

Type : RetractionIn

Auteurs

Song Zheng (S)

Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA.

Ai Tran (A)

Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Colchester, VT 05446, USA.

Alyson M Curry (AM)

Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23219, USA. ceny2@vcu.edu.

Dawanna S White (DS)

Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23219, USA. ceny2@vcu.edu.

Yana Cen (Y)

Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23219, USA. ceny2@vcu.edu and Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, VA 23219, USA.

Classifications MeSH